ADVB
Advanced Biomed Inc.
Next earnings Oct 6, 2026
$4.49
▼ -10.02%$4.49▼ -68.38%
over 1Y
L $3.71EODHDH $15.99
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-10.0%
1W-10.0%
1M+15.7%
3M+7.3%
YTD-25.7%
1Y-68.4%
Hold
Conviction
Horizon
Medium (3–12mo)
Conservative balance sheet (liabilities/equity 0.87x).
Return on equity -93.7% · latest
Advanced Biomed Inc. shows limited reported revenue, and -93.7% ROE.
Financials · annual, by fiscal year
| Line item | FY24 | FY25 |
|---|---|---|
| Revenue | — | — |
| Gross profit | — | — |
| Operating income | — | — |
| Net income | -$2.78M | -$3.26M |
| Diluted EPS | -$0.14 | -$0.16 |
| Net margin | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$94.3M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-3.4%
FCF yield-6.0%
Quality & risk
ROIC (est.)—
Free cash flow-$5.86M
Total debt—
Net cash$2.90M
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗DEF 14APeriod ending 2026-06-302026-06-04open ↗10-QPeriod ending 2026-03-312026-05-15open ↗8-KPeriod ending 2026-04-282026-05-01open ↗8-KPeriod ending 2026-04-132026-04-14open ↗8-KPeriod ending 2026-04-022026-04-03open ↗8-KPeriod ending 2026-03-252026-03-30open ↗8-KPeriod ending 2026-03-122026-03-16open ↗8-KPeriod ending 2026-02-202026-02-26open ↗10-QPeriod ending 2025-12-312026-02-13open ↗8-K/APeriod ending 2025-06-062026-02-10open ↗8-KPeriod ending 2026-01-282026-02-02open ↗8-KPeriod ending 2026-01-262026-01-27open ↗
Frequently asked
- Is Advanced Biomed Inc. (ADVB) a buy?
- ADVB currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.87x).
- What is Advanced Biomed Inc.'s quality score?
- ADVB scores 34.641025641025635/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001941029, latest 10-Q filed 2026-05-15) · EODHD · as of 6/23/2026, 12:41:32 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.